All products5-Amino-1MQ

Size
- 150 mg — $150.00 CAD — Available
Research focus
A methylquinolinium compound associated with research on inhibitors of nicotinamide N-methyltransferase (NNMT).
In simple words
5-Amino-1MQ is a methylquinolinium small molecule associated with research on NNMT, an enzyme involved in cellular metabolism. 5-Amino-1MQ is not a peptide; the selected inhibitor-series study does not verify this vial’s exact salt, structure or contents.
The cited abstract describes an inhibitor series. It does not verify the exact salt, structure or contents of this catalogue product.
Research references
Reviewed 2026-10-26
Preclinical — cells and mice
Cultured adipocytes and diet-induced-obese mice; counts not stated in the reviewed abstract.
A series of NNMT inhibitors was studied for selectivity and cellular metabolism. A potent inhibitor reduced weight and adipose measures in the mouse model.
The abstract discusses a compound series, not verified contents of this vial. No human efficacy or long-term safety follows from these experiments. Full-text verification of the exact catalogue salt/form was unavailable.
PMID 29155147. Indexed abstract checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
Resources
Identity search; no unambiguous compound record assigned to this listing. Check forms and synonyms carefully.
PubChemMechanism and target search. Automated access returned 403; DrugBank was not used to substantiate claims or approval status.
DrugBankProtein/precursor search, not a record of the supplied vial. Synthetic compounds and lab supplies may have no matching protein entry.
UniProtBioactivity search. Assay results depend on the tested compound, target and experimental conditions.
ChEMBLExplore indexed literature. Search results are not supporting citations; selected verified publications appear above.
PubMedExplore registrations. A match or completed study does not establish efficacy, approval or relevance to this vial.
ClinicalTrials.govEvidence on studied compounds does not establish the identity, purity, safety, or regulatory approval of the catalogue vial. No Canadian regulatory status is assessed here.
Research questions about 5-Amino-1MQ
What is 5-Amino-1MQ?
5-Amino-1MQ is a methylquinolinium small molecule associated with research on NNMT, an enzyme involved in cellular metabolism. 5-Amino-1MQ is not a peptide; the selected inhibitor-series study does not verify this vial’s exact salt, structure or contents.
What types of research are cited for 5-Amino-1MQ?
The 5-Amino-1MQ profile contains the following selected evidence. This is not a systematic review or a complete inventory of research.
Methylquinolinium NNMT inhibitors (2018): Preclinical — cells and mice
Publication: Methylquinolinium NNMT inhibitorsWho or what was studied in the selected 5-Amino-1MQ references?
Methylquinolinium NNMT inhibitors (2018): Cultured adipocytes and diet-induced-obese mice; counts not stated in the reviewed abstract.
Publication: Methylquinolinium NNMT inhibitorsWhat identity distinctions matter for 5-Amino-1MQ?
The cited abstract describes an inhibitor series. It does not verify the exact salt, structure or contents of this catalogue product.
What do the selected 5-Amino-1MQ studies not establish?
Methylquinolinium NNMT inhibitors (2018): The abstract discusses a compound series, not verified contents of this vial. No human efficacy or long-term safety follows from these experiments. Full-text verification of the exact catalogue salt/form was unavailable.
Publication: Methylquinolinium NNMT inhibitorsThese studies do not establish the identity, purity, safety or effects of the MXC 5-Amino-1MQ vial. Findings in one formulation, population or experimental model should not be assumed to apply to another.